Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fausto Titti

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Immunogenetics|April 2, 2009
Mhc haplotype H6 is associated with sustained control of SIVmac251 infection in Mauritian cynomolgus macaquesEdward T Mee, Neil Berry, Claire Ham, et al.
Journal of Medical Virology|September 5, 2002
Infection of simian B lymphoblastoid cells with simian immunodeficiency virus is associated with upregulation of CD23 and CD40 cell surface markersFausto Titti, Rita Zamarchi, Maria Teresa Maggiorella, et al.
Vaccine|February 23, 2011
A combination HIV vaccine based on Tat and Env proteins was immunogenic and protected macaques from mucosal SHIV challenge in a pilot studyFlavia Ferrantelli, Maria Teresa Maggiorella, Ilaria Schiavoni, et al.
Journal of Medical Primatology|November 5, 2004
T-cell-mediated protective efficacy of a systemic vaccine approach in cynomolgus monkeys after SIV mucosal challengeZuleika Michelini, Donatella R M Negri, Silvia Baroncelli, et al.
The Journal of General Virology|April 24, 2004
Protective efficacy of a multicomponent vector vaccine in cynomolgus monkeys after intrarectal simian immunodeficiency virus challengeDonatella R M Negri, Silvia Baroncelli, Stefania Catone, et al.
Vaccine|May 20, 2008
Comparative study of Tat vaccine regimens in Mauritian cynomolgus and Indian rhesus macaques: influence of Mauritian MHC haplotypes on susceptibility/resistance to SHIV(89.6P) infectionRuth H Florese, Roger W Wiseman, David Venzon, et al.
Viral Immunology|March 31, 2009
Containment of infection in tat vaccinated monkeys after rechallenge with a higher dose of SHIV89.6P(cy243)Alessandra Borsetti, Silvia Baroncelli, Maria Teresa Maggiorella, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 24, 2009
HIV-1 Tat addresses dendritic cells to induce a predominant Th1-type adaptive immune response that appears prevalent in the asymptomatic stage of infectionEmanuele Fanales-Belasio, Sonia Moretti, Valeria Fiorelli, et al.
Plos One|October 31, 2014
Biocompatible anionic polymeric microspheres as priming delivery system for effetive HIV/AIDS Tat-based vaccinesFausto Titti, Maria T Maggiorella, Flavia Ferrantelli, et al.
Vaccine|August 17, 2004
Long-term protection against SHIV89.6P replication in HIV-1 Tat vaccinated cynomolgus monkeysMaria Teresa Maggiorella, Silvia Baroncelli, Zuleika Michelini, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Immunogenetics|April 2, 2009
Mhc haplotype H6 is associated with sustained control of SIVmac251 infection in Mauritian cynomolgus macaquesEdward T Mee, Neil Berry, Claire Ham, et al.
Journal of Medical Virology|September 5, 2002
Infection of simian B lymphoblastoid cells with simian immunodeficiency virus is associated with upregulation of CD23 and CD40 cell surface markersFausto Titti, Rita Zamarchi, Maria Teresa Maggiorella, et al.
Vaccine|February 23, 2011
A combination HIV vaccine based on Tat and Env proteins was immunogenic and protected macaques from mucosal SHIV challenge in a pilot studyFlavia Ferrantelli, Maria Teresa Maggiorella, Ilaria Schiavoni, et al.
Journal of Medical Primatology|November 5, 2004
T-cell-mediated protective efficacy of a systemic vaccine approach in cynomolgus monkeys after SIV mucosal challengeZuleika Michelini, Donatella R M Negri, Silvia Baroncelli, et al.
The Journal of General Virology|April 24, 2004
Protective efficacy of a multicomponent vector vaccine in cynomolgus monkeys after intrarectal simian immunodeficiency virus challengeDonatella R M Negri, Silvia Baroncelli, Stefania Catone, et al.
Vaccine|May 20, 2008
Comparative study of Tat vaccine regimens in Mauritian cynomolgus and Indian rhesus macaques: influence of Mauritian MHC haplotypes on susceptibility/resistance to SHIV(89.6P) infectionRuth H Florese, Roger W Wiseman, David Venzon, et al.
Viral Immunology|March 31, 2009
Containment of infection in tat vaccinated monkeys after rechallenge with a higher dose of SHIV89.6P(cy243)Alessandra Borsetti, Silvia Baroncelli, Maria Teresa Maggiorella, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 24, 2009
HIV-1 Tat addresses dendritic cells to induce a predominant Th1-type adaptive immune response that appears prevalent in the asymptomatic stage of infectionEmanuele Fanales-Belasio, Sonia Moretti, Valeria Fiorelli, et al.
Plos One|October 31, 2014
Biocompatible anionic polymeric microspheres as priming delivery system for effetive HIV/AIDS Tat-based vaccinesFausto Titti, Maria T Maggiorella, Flavia Ferrantelli, et al.
Vaccine|August 17, 2004
Long-term protection against SHIV89.6P replication in HIV-1 Tat vaccinated cynomolgus monkeysMaria Teresa Maggiorella, Silvia Baroncelli, Zuleika Michelini, et al.
Pageof 4